Boston, MA -- (SBWIRE) -- 10/17/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: TOKYO ELECTRON LTD(OTCMKTS:TOELY), Delcath Systems, Inc.(NASDAQ:DCTH), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Morgan Stanley(NYSE:MS).
TOKYO ELECTRON LTD(OTCMKTS:TOELY) opened its shares at the price of $13.94 for the day. Its closing price was $13.94 after gaining +0.65% for the day. The company traded with the total volume of 195,898 shares, while its average trading volume remained 357,832 shares. The beta of TOELY stands at 1.33.
Tokyo Electron Limited, together with its subsidiaries, develops, manufactures, and sells semiconductor production equipment (SPE), flat panel display (FPD), and photovoltaic cell (PV) production equipment in the United States, Europe, and Asia
For How Long TOELY will Fight for Profitability? Read This Trend Analysis report
Delcath Systems, Inc.(NASDAQ:DCTH) percentage change plunged -2.36% to close at $0.410 with the total traded volume of 1.47 million shares, and average volume of 4.18 million. The 52 week range of the stock remained $0.29 - $2.19, while its day lowest price was $0.39 and it hit its day highest price at $0.43.
Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology. The company?s proprietary technology enables the administration of high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents.
Has DCTH Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) started its trading session with the price of $284 and closed at $268 by scoring -463%. ARNA stocks traded with total volume of 3.92 million shares, while the average trading volume remained 5.55 million shares. The beta of ARNA stands at 0.05. Day range of the stock was $4.57 -$4.71.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Morgan Stanley(NYSE:MS) ended its day with the gain of +2.29% and closed at the price of $28.63 after opening at $28.18. Stock traded during its last trading session with the total volume of 15.47 million shares, as compared to its average volume of 13.87 million shares.
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide.
Why Should Investors Buy MS After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)